CPF Texas’s Novartis NVS Stock Holding History

CPF Texas’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$867K	Hold	11,235	–	–	0.41%	67
2018 Q2	$760K	Hold	11,235	–	–	0.4%	64
2018 Q1	$814K	Hold	11,235	–	–	0.42%	63
2017 Q4	$845K	Buy	+11,235	New	+$848K	0.41%	60

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

CPF Texas's NVS Position: Q3 2018 in Review

CPF Texas held its Novartis (NVS) position steady in Q3 2018 at 11,235 shares worth $867K. The position accounts for 0.41% of the portfolio, ranked #67.

CPF Texas first reported a position in NVS in Q4 2017 and has held it in 4 quarters since. 1,029 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

CPF Texas held 11,235 shares of Novartis worth $867K as of Q3 2018.
CPF Texas left its Novartis share count unchanged in Q3 2018.
Novartis made up 0.41% of CPF Texas's portfolio in Q3 2018, its #67 holding.
CPF Texas first reported a position in Novartis in Q4 2017 and has held it in 4 quarters since.
1,029 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.